ProfileGDS5822 / ILMN_2711651
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 96% 94% 91% 95% 94% 92% 96% 94% 95% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1134496
GSM1276600PDAC Late Ablation Control 2869.294
GSM1276601PDAC Late Ablation Control 3661.691
GSM1276602PDAC Late Ablation 11169.195
GSM1276603PDAC Late Ablation 2954.194
GSM1276604PDAC Late Ablation 3807.892
GSM1303940PDAC Late Ablation_anti-CTLA4 11421.996
GSM1303941PDAC Late Ablation_anti-CTLA4 21141.594
GSM1303942PDAC Late Ablation_anti-CTLA4 31231.895